| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 35 | 2023 | 477 | 8.760 |
Why?
|
| CD4-Positive T-Lymphocytes | 23 | 2022 | 488 | 4.830 |
Why?
|
| Cyclin-Dependent Kinase 9 | 17 | 2017 | 29 | 3.830 |
Why?
|
| Positive Transcriptional Elongation Factor B | 14 | 2019 | 18 | 3.160 |
Why?
|
| Host-Pathogen Interactions | 8 | 2019 | 261 | 2.910 |
Why?
|
| Cyclin T | 22 | 2019 | 32 | 2.680 |
Why?
|
| Virus Replication | 15 | 2019 | 630 | 2.590 |
Why?
|
| Virus Latency | 13 | 2022 | 63 | 2.530 |
Why?
|
| Cyclins | 13 | 2015 | 100 | 2.520 |
Why?
|
| HIV Infections | 20 | 2023 | 2038 | 2.390 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 9 | 2019 | 32 | 1.810 |
Why?
|
| Gene Expression Regulation, Viral | 11 | 2017 | 130 | 1.790 |
Why?
|
| RNA Polymerase II | 7 | 2018 | 87 | 1.520 |
Why?
|
| Anti-HIV Agents | 3 | 2021 | 348 | 1.360 |
Why?
|
| Macrophages | 9 | 2009 | 689 | 1.280 |
Why?
|
| MicroRNAs | 7 | 2015 | 917 | 1.270 |
Why?
|
| Cyclin-Dependent Kinases | 4 | 2018 | 86 | 1.200 |
Why?
|
| Viral Nonstructural Proteins | 5 | 2019 | 195 | 1.190 |
Why?
|
| Virus Activation | 4 | 2022 | 86 | 1.160 |
Why?
|
| HIV Long Terminal Repeat | 9 | 2017 | 18 | 1.140 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 2 | 2019 | 15 | 1.090 |
Why?
|
| Monocytes | 6 | 2012 | 342 | 0.950 |
Why?
|
| Influenza A virus | 5 | 2019 | 152 | 0.930 |
Why?
|
| Hydroxamic Acids | 2 | 2016 | 60 | 0.930 |
Why?
|
| RNA, Viral | 5 | 2019 | 562 | 0.880 |
Why?
|
| RNA, Long Noncoding | 2 | 2018 | 240 | 0.850 |
Why?
|
| Transcription, Genetic | 7 | 2018 | 1422 | 0.830 |
Why?
|
| Gene Expression Regulation | 8 | 2019 | 2438 | 0.770 |
Why?
|
| HIV Seropositivity | 1 | 2023 | 128 | 0.770 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2023 | 233 | 0.740 |
Why?
|
| HIV | 3 | 2016 | 187 | 0.730 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2021 | 7 | 0.710 |
Why?
|
| Transcription Factors | 9 | 2017 | 2493 | 0.700 |
Why?
|
| Gene Products, tat | 5 | 2016 | 27 | 0.680 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 687 | 0.670 |
Why?
|
| Cell Line | 10 | 2019 | 2719 | 0.650 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2012 | 123 | 0.630 |
Why?
|
| Jurkat Cells | 6 | 2021 | 82 | 0.610 |
Why?
|
| Karyopherins | 2 | 2019 | 36 | 0.600 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 122 | 0.580 |
Why?
|
| Neuralgia | 3 | 2025 | 52 | 0.580 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2016 | 86 | 0.570 |
Why?
|
| Phosphorylation | 8 | 2016 | 1608 | 0.570 |
Why?
|
| Immune Evasion | 1 | 2018 | 38 | 0.570 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 490 | 0.560 |
Why?
|
| Cell Nucleus | 4 | 2019 | 587 | 0.530 |
Why?
|
| Humans | 58 | 2025 | 132089 | 0.520 |
Why?
|
| HeLa Cells | 8 | 2012 | 731 | 0.520 |
Why?
|
| Cells, Cultured | 7 | 2021 | 3037 | 0.520 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 323 | 0.510 |
Why?
|
| Lymphocyte Activation | 5 | 2013 | 679 | 0.500 |
Why?
|
| Depsipeptides | 1 | 2016 | 11 | 0.490 |
Why?
|
| Phenylenediamines | 1 | 2016 | 30 | 0.480 |
Why?
|
| Pain | 2 | 2016 | 457 | 0.470 |
Why?
|
| PDZ Domains | 2 | 2012 | 10 | 0.470 |
Why?
|
| Leprosy | 1 | 2015 | 20 | 0.460 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 1280 | 0.460 |
Why?
|
| Disulfiram | 1 | 2015 | 33 | 0.450 |
Why?
|
| Indoles | 1 | 2016 | 201 | 0.440 |
Why?
|
| Influenza in Birds | 2 | 2014 | 28 | 0.430 |
Why?
|
| RNA-Binding Proteins | 5 | 2010 | 604 | 0.430 |
Why?
|
| Down-Regulation | 5 | 2018 | 677 | 0.430 |
Why?
|
| RNA, Small Nuclear | 4 | 2008 | 46 | 0.400 |
Why?
|
| Membrane Proteins | 2 | 2011 | 1610 | 0.400 |
Why?
|
| Transcriptional Activation | 5 | 2019 | 429 | 0.390 |
Why?
|
| Cell Cycle | 1 | 2015 | 611 | 0.390 |
Why?
|
| Viral Proteins | 2 | 2011 | 358 | 0.390 |
Why?
|
| Apoptosis | 3 | 2022 | 1892 | 0.380 |
Why?
|
| Interferon-beta | 1 | 2012 | 54 | 0.380 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2012 | 81 | 0.370 |
Why?
|
| RNA, Messenger | 7 | 2011 | 2674 | 0.370 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 573 | 0.370 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 2 | 2014 | 61 | 0.370 |
Why?
|
| Tight Junctions | 1 | 2011 | 40 | 0.360 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 201 | 0.360 |
Why?
|
| Protein Binding | 5 | 2019 | 1730 | 0.350 |
Why?
|
| Virus Integration | 3 | 2016 | 39 | 0.340 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 624 | 0.340 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2010 | 17 | 0.330 |
Why?
|
| Analgesics | 2 | 2025 | 127 | 0.330 |
Why?
|
| Viruses | 1 | 2011 | 127 | 0.320 |
Why?
|
| Antigens, Nuclear | 1 | 2010 | 56 | 0.320 |
Why?
|
| Cell Differentiation | 6 | 2009 | 1960 | 0.320 |
Why?
|
| Calcium Signaling | 1 | 2012 | 255 | 0.320 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 1882 | 0.310 |
Why?
|
| Protein Transport | 3 | 2019 | 369 | 0.310 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 141 | 0.300 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2005 | 77 | 0.280 |
Why?
|
| Gene Expression | 3 | 2012 | 1558 | 0.280 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 233 | 0.280 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2006 | 354 | 0.270 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 219 | 0.270 |
Why?
|
| DNA Repair | 1 | 2010 | 565 | 0.260 |
Why?
|
| Phorbol Esters | 1 | 2006 | 21 | 0.260 |
Why?
|
| Lipopolysaccharides | 2 | 2005 | 306 | 0.250 |
Why?
|
| Genes, tat | 1 | 2006 | 10 | 0.250 |
Why?
|
| DNA | 3 | 2006 | 1473 | 0.240 |
Why?
|
| Peptidoglycan | 1 | 2005 | 22 | 0.240 |
Why?
|
| Genes | 1 | 2006 | 313 | 0.240 |
Why?
|
| Up-Regulation | 3 | 2017 | 876 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 1280 | 0.230 |
Why?
|
| Interleukin-10 | 1 | 2006 | 187 | 0.230 |
Why?
|
| Electric Stimulation Therapy | 1 | 2025 | 85 | 0.220 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2018 | 123 | 0.220 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 660 | 0.210 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2017 | 61 | 0.200 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 119 | 0.200 |
Why?
|
| Lectins, C-Type | 1 | 2003 | 70 | 0.200 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2023 | 39 | 0.200 |
Why?
|
| Transfection | 3 | 2012 | 996 | 0.200 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2016 | 266 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2012 | 251 | 0.190 |
Why?
|
| Proviruses | 2 | 2016 | 19 | 0.180 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 1977 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2005 | 712 | 0.180 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 450 | 0.170 |
Why?
|
| Polyadenylation | 2 | 2018 | 50 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 219 | 0.170 |
Why?
|
| Protein Phosphatase 2C | 2 | 2012 | 60 | 0.160 |
Why?
|
| RNA Interference | 2 | 2012 | 514 | 0.160 |
Why?
|
| In Vitro Techniques | 3 | 2006 | 862 | 0.160 |
Why?
|
| RNA Transport | 1 | 2019 | 8 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2021 | 178 | 0.160 |
Why?
|
| Isoquinolines | 1 | 2019 | 40 | 0.150 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2019 | 34 | 0.150 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 1743 | 0.150 |
Why?
|
| Cytoplasm | 1 | 2019 | 268 | 0.150 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 806 | 0.140 |
Why?
|
| Animals | 10 | 2022 | 34798 | 0.140 |
Why?
|
| Chemokine CCL19 | 1 | 2017 | 6 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 136 | 0.140 |
Why?
|
| Ionomycin | 1 | 2017 | 18 | 0.140 |
Why?
|
| Immunity, Innate | 2 | 2015 | 413 | 0.140 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2017 | 41 | 0.140 |
Why?
|
| Multienzyme Complexes | 2 | 2010 | 85 | 0.130 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 684 | 0.130 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 90 | 0.130 |
Why?
|
| Histone Code | 1 | 2017 | 49 | 0.130 |
Why?
|
| Immunologic Factors | 1 | 2018 | 183 | 0.130 |
Why?
|
| Epithelial Cells | 2 | 2018 | 903 | 0.130 |
Why?
|
| Binding Sites | 2 | 2010 | 1256 | 0.130 |
Why?
|
| Base Sequence | 3 | 2006 | 2899 | 0.130 |
Why?
|
| Drug Design | 1 | 2017 | 161 | 0.120 |
Why?
|
| SAM Domain and HD Domain-Containing Protein 1 | 1 | 2015 | 5 | 0.120 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 12 | 0.120 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2015 | 26 | 0.120 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2015 | 37 | 0.120 |
Why?
|
| Benzamides | 1 | 2016 | 124 | 0.120 |
Why?
|
| Recombinases | 1 | 2015 | 26 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2021 | 799 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2006 | 365 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 517 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1203 | 0.110 |
Why?
|
| Acetaldehyde Dehydrogenase Inhibitors | 1 | 2015 | 5 | 0.110 |
Why?
|
| Texas | 1 | 2023 | 3629 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 1044 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2016 | 615 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 385 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2010 | 762 | 0.110 |
Why?
|
| Birds | 2 | 2014 | 86 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1284 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 396 | 0.110 |
Why?
|
| Histones | 1 | 2017 | 534 | 0.100 |
Why?
|
| Mutation | 3 | 2019 | 6228 | 0.100 |
Why?
|
| Proteomics | 1 | 2017 | 596 | 0.100 |
Why?
|
| Blotting, Northern | 2 | 2003 | 252 | 0.100 |
Why?
|
| DEAD Box Protein 58 | 1 | 2012 | 12 | 0.100 |
Why?
|
| Guanylate Kinases | 1 | 2012 | 19 | 0.100 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2012 | 21 | 0.100 |
Why?
|
| Poly I-C | 1 | 2012 | 24 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2012 | 13 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2012 | 15 | 0.090 |
Why?
|
| RNA Precursors | 1 | 2012 | 66 | 0.090 |
Why?
|
| Discs Large Homolog 1 Protein | 1 | 2011 | 8 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2018 | 699 | 0.090 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 126 | 0.090 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2011 | 61 | 0.090 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 68 | 0.090 |
Why?
|
| Viral Matrix Proteins | 1 | 2011 | 109 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 146 | 0.090 |
Why?
|
| Lymphoma, T-Cell | 1 | 2011 | 62 | 0.090 |
Why?
|
| Virulence Factors | 1 | 2012 | 187 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 397 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 143 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2016 | 745 | 0.080 |
Why?
|
| Ku Autoantigen | 1 | 2010 | 21 | 0.080 |
Why?
|
| Threonine | 1 | 2010 | 61 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1722 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2010 | 151 | 0.080 |
Why?
|
| Flavonoids | 1 | 2010 | 86 | 0.080 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 26 | 0.080 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2009 | 20 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 162 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 348 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2010 | 422 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 326 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2011 | 584 | 0.070 |
Why?
|
| Casein Kinase I | 1 | 2008 | 12 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2011 | 294 | 0.070 |
Why?
|
| Piperidines | 1 | 2010 | 235 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 166 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 246 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2008 | 179 | 0.070 |
Why?
|
| Genes, Dominant | 1 | 2008 | 250 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 764 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2010 | 925 | 0.060 |
Why?
|
| Mice | 4 | 2022 | 18466 | 0.060 |
Why?
|
| Blood Cells | 1 | 2005 | 54 | 0.060 |
Why?
|
| Macrophage Activation | 1 | 2005 | 65 | 0.060 |
Why?
|
| RNA | 1 | 2009 | 552 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 605 | 0.060 |
Why?
|
| Spleen | 1 | 2006 | 270 | 0.060 |
Why?
|
| CD52 Antigen | 1 | 2005 | 7 | 0.060 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Paxillin | 1 | 2005 | 13 | 0.060 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2005 | 18 | 0.060 |
Why?
|
| Receptors, Interleukin | 1 | 2005 | 35 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 380 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2019 | 827 | 0.060 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 15 | 0.060 |
Why?
|
| Gene Products, nef | 1 | 2004 | 17 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 459 | 0.050 |
Why?
|
| Leukocytes | 1 | 2005 | 209 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2006 | 389 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2005 | 118 | 0.050 |
Why?
|
| Angiotensin II Type 2 Receptor Blockers | 1 | 2023 | 5 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 112 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 143 | 0.050 |
Why?
|
| Solubility | 1 | 2003 | 125 | 0.050 |
Why?
|
| Transcription Initiation Site | 1 | 2003 | 33 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 282 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2006 | 771 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 129 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 480 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2023 | 68 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2005 | 431 | 0.050 |
Why?
|
| CD11c Antigen | 1 | 2002 | 40 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2005 | 442 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2005 | 375 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 401 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 233 | 0.050 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2022 | 19 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2003 | 615 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2022 | 110 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 1044 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2004 | 595 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 7104 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2009 | 3861 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2022 | 501 | 0.040 |
Why?
|
| Freund's Adjuvant | 1 | 2020 | 27 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2020 | 26 | 0.040 |
Why?
|
| Morphine | 1 | 2020 | 85 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 1248 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2022 | 455 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2002 | 448 | 0.040 |
Why?
|
| Genome, Human | 1 | 2006 | 1331 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2012 | 4704 | 0.040 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2019 | 72 | 0.040 |
Why?
|
| Autophagy | 1 | 2022 | 426 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 388 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 4685 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3770 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 588 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 494 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2018 | 84 | 0.030 |
Why?
|
| Benzylidene Compounds | 1 | 2017 | 5 | 0.030 |
Why?
|
| Piperidones | 1 | 2017 | 7 | 0.030 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 11 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2018 | 114 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 1799 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 31575 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 207 | 0.030 |
Why?
|
| Reverse Transcription | 1 | 2016 | 5 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 191 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2019 | 791 | 0.030 |
Why?
|
| Male | 4 | 2020 | 64967 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 143 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2669 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 589 | 0.030 |
Why?
|
| Aged | 1 | 2013 | 21438 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 404 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1519 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1294 | 0.020 |
Why?
|
| Middle Aged | 1 | 2013 | 28998 | 0.020 |
Why?
|
| Time Factors | 1 | 2002 | 6448 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 663 | 0.020 |
Why?
|
| Research Design | 1 | 2016 | 742 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 468 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 1117 | 0.020 |
Why?
|
| Lung | 1 | 2018 | 1559 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1077 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 540 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 51 | 0.020 |
Why?
|
| Carcinoma | 1 | 2011 | 299 | 0.020 |
Why?
|
| Female | 3 | 2021 | 70695 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4754 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 671 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 285 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2508 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 1659 | 0.010 |
Why?
|